Lancet Rheumatology

Scope & Guideline

Elevating the discourse in rheumatology and immunology.

Introduction

Welcome to the Lancet Rheumatology information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Lancet Rheumatology, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2665-9913
PublisherELSEVIER
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2019 to 2024
AbbreviationLANCET RHEUMATOL / Lancet Rheumatol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The Lancet Rheumatology journal focuses on advancing the understanding and treatment of rheumatic diseases through high-quality research and clinical studies. Its primary aim is to provide a platform for innovative research that can improve patient outcomes and guide clinical practice.
  1. Rheumatic Disease Research:
    The journal emphasizes research on various rheumatic conditions, including systemic lupus erythematosus, rheumatoid arthritis, and Sjögren's syndrome, exploring their pathophysiology, diagnosis, and management.
  2. Clinical Trials and Interventions:
    A significant focus is on clinical trials evaluating new therapies, treatment strategies, and interventions aimed at improving patient care and outcomes in rheumatology.
  3. Patient-Centered Approaches:
    The journal promotes research that incorporates patient perspectives, emphasizing the importance of patient-reported outcomes and engagement in treatment decisions.
  4. Emerging Therapies and Precision Medicine:
    A core area of interest involves exploring novel therapeutics, including biologics and targeted therapies, and their application in personalized medicine for rheumatic diseases.
  5. Public Health and Epidemiology:
    Research addressing the epidemiology of rheumatic diseases, health disparities, and the impact of socioeconomic factors on disease management is also a critical focus.
  6. COVID-19 and Autoimmunity:
    Given the recent pandemic, the journal has increasingly published studies on the intersection of COVID-19 and rheumatic diseases, including vaccine responses and management strategies.
The Lancet Rheumatology has been at the forefront of several emerging themes in rheumatology research, reflecting the evolving landscape of the field.
  1. Digital Health and Telemedicine:
    Recent publications highlight the growing integration of digital health technologies and telemedicine in managing rheumatic diseases, especially in the context of the COVID-19 pandemic.
  2. Vaccine Research in Autoimmune Diseases:
    There is a marked increase in research focused on vaccine responses among patients with autoimmune conditions, particularly regarding COVID-19 vaccinations and their implications for treatment.
  3. Health Equity and Social Determinants:
    Emerging themes include a focus on health equity, social determinants of health, and their impact on the management of rheumatic diseases, addressing disparities in care.
  4. Patient Engagement and Self-Management:
    There is a rising trend in research exploring patient engagement strategies and self-management approaches, emphasizing the importance of involving patients in their care.
  5. Precision Medicine and Biomarkers:
    The journal increasingly features studies on precision medicine, with a focus on identifying biomarkers that can guide treatment decisions and improve patient outcomes.
  6. COVID-19 Impact Studies:
    The ongoing impact of COVID-19 on rheumatology care continues to be a significant area of research, with studies evaluating the effects on disease management and patient safety.

Declining or Waning

While the journal has seen growth in certain areas, some themes have become less prominent over recent years, indicating a potential shift in research focus.
  1. Traditional Therapies:
    There has been a noticeable decline in papers focused on traditional treatments for rheumatic diseases, such as corticosteroids and non-steroidal anti-inflammatory drugs, as the field shifts towards biologics and targeted therapies.
  2. Basic Science Research:
    The journal has published fewer studies centered exclusively on basic science, such as bench research, as the emphasis moves towards translational and clinical research that directly impacts patient care.
  3. Longitudinal Studies in Established Cohorts:
    Research utilizing long-term follow-up of established cohorts has decreased, potentially as the emphasis shifts towards more immediate clinical trials and interventions.
  4. Single-Center Studies:
    There appears to be a waning interest in single-center studies, with a preference for multicenter collaborations that can provide broader insights and more robust data.

Similar Journals

Rheumatology and Therapy

Pioneering research that transforms patient outcomes.
Publisher: SPRINGERISSN: 2198-6576Frequency: 4 issues/year

Rheumatology and Therapy, published by Springer, stands as a prominent open-access journal within the fields of Immunology and Allergy and Rheumatology. Since its inception in 2014, the journal has made significant contributions to advancing the understanding, diagnosis, and treatment of rheumatic diseases, garnering a solid reputation with an impact factor that reflects its rigorous peer-review process and scholarly influence. Currently ranked in the Q2 quartile for both its categories according to 2023 metrics, it occupies a significant position among its peers, standing at Rank #21 out of 73 in Medicine Rheumatology and Rank #101 out of 233 for Medicine Immunology and Allergy. The journal's scope encompasses cutting-edge research, reviews, and clinical studies that aim to bridge the gap between laboratory findings and patient care, making it an invaluable resource for researchers, clinicians, and students alike. With its commitment to open access, Rheumatology and Therapy ensures that high-quality research is available to a global audience, fostering collaboration and innovation in rheumatology and immunology. To learn more, visit their official site and explore the wealth of knowledge available.

Egyptian Rheumatologist

Illuminating the path to improved patient outcomes.
Publisher: ELSEVIERISSN: 1110-1164Frequency: 4 issues/year

The Egyptian Rheumatologist is a peer-reviewed Open Access journal dedicated to advancing the field of rheumatology. Published by Elsevier since 2011, the journal aims to disseminate high-quality research, clinical innovations, and reviews that cover a wide range of topics related to autoimmune diseases, arthritis, and musculoskeletal disorders. With an ISSN of 1110-1164 and an E-ISSN of 2090-2433, it has achieved a respectable rank of #50 out of 73 in the medicine/rheumatology category according to Scopus, positioning it in the 32nd percentile among its peers. Operating from its base in Amsterdam, Netherlands, the journal provides an accessible platform for researchers, professionals, and students, encouraging a collaborative exchange of cutting-edge knowledge that is essential for the ongoing developments in rheumatologic care and research. The Open Access model ensures that critical findings and advancements are available to a global audience, fostering further research and education within this vital field.

BMC Rheumatology

Connecting experts to elevate rheumatological science.
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

BMC Rheumatology is a vital open-access journal that has been disseminating high-quality research in the field of rheumatology since its inception in 2017. Published by Springer Nature, this journal provides a platform for original research, reviews, and clinical studies that advance the understanding and treatment of rheumatic diseases. With a commendable impact factor and ranked in the second quartile (Q2) for Rheumatology as of 2023, BMC Rheumatology exemplifies expertise, contributing significantly to the medical community's dialogue. Researchers, professionals, and students will find valuable insights within its pages, as it caters to a diverse audience through its commitment to open-access publishing, facilitating knowledge sharing without barriers. Based in the United Kingdom and indexed in Scopus, the journal continues to thrive with a steady convergence of academic excellence through 2024, making it an indispensable resource for those dedicated to advancing rheumatological science.

Pediatric Rheumatology

Advancing pediatric care through groundbreaking research.
Publisher: BMCISSN: Frequency: 1 issue/year

Pediatric Rheumatology is a leading peer-reviewed open access journal published by BMC, dedicated to disseminating high-quality research in the field of pediatric rheumatology. Since its inception in 2007, the journal has established itself as a vital resource for healthcare professionals, researchers, and students focused on pediatric immunology, rheumatology, and child health, maintaining an impressive Q1 ranking in Pediatrics and Q2 in Immunology and Allergy as well as Rheumatology for 2023. It is recognized for its impact on advancing knowledge and clinical practice, with significant contributions noted in various studies and case reports. With access options that embrace the ethos of open science, all articles published in Pediatric Rheumatology are freely available, promoting collaborative research and discussion among practitioners across the globe. The journal welcomes submissions that encapsulate innovative research, clinical trials, and reviews that address both current challenges and advancements within the pediatric rheumatology landscape.

Current Rheumatology Reports

Advancing knowledge in rheumatology research.
Publisher: SPRINGERISSN: 1523-3774Frequency: 12 issues/year

Current Rheumatology Reports is a premier journal dedicated to advancing the field of rheumatology, published by Springer. With an esteemed Q1 category ranking in Rheumatology as of 2023 and a remarkable Scopus rank of 6 out of 73, this journal stands at the forefront of research dissemination, boasting an impressive percentile ranking in the 92nd. Since its inception in 1999, Current Rheumatology Reports has provided a critical platform for the latest findings in rheumatological diseases, treatment strategies, and clinical practices. Although it currently does not offer Open Access options, the journal's rigorous peer-review process ensures high-quality publications that are essential for researchers, clinicians, and students alike. By keeping the community informed of key developments, this journal plays a vital role in shaping contemporary rheumatological research and practice, thereby facilitating the advancement of patient care worldwide.

Reumatismo

Connecting researchers and practitioners in the world of rheumatology.
Publisher: PAGEPRESS PUBLISSN: 0048-7449Frequency: 4 issues/year

Reumatismo is a distinguished Open Access journal dedicated to the field of rheumatology, published by PAGEPRESS PUBL since 2001. With a rich history dating back to 1952, this journal has been pivotal in disseminating vital research on rheumatic diseases and related disorders. Based in Italy, Reumatismo has earned a reputation for its quality and relevance, achieving a Q3 category ranking in the 2023 Scopus metrics for Rheumatology, reflecting its significant contributions to the field. The journal is committed to providing a platform for the latest scientific developments and clinical innovations, thus aiding researchers, healthcare professionals, and students striving to enhance understanding and treatment of rheumatic conditions. For those seeking to access comprehensive research articles and studies, Reumatismo boasts an open access policy, ensuring that knowledge is freely available to all, fostering collaboration and advancement in rheumatology worldwide.

Arthritis & Rheumatology

Leading the Charge in Rheumatology and Allergy Research
Publisher: WILEYISSN: 2326-5191Frequency: 12 issues/year

Arthritis & Rheumatology is a leading journal dedicated to the advancement of knowledge in the fields of rheumatology, immunology, and allergy. Published by WILEY in the United Kingdom, this prestigious journal boasts an impressive impact factor and a prominent reputation, ranking in the Q1 category across multiple disciplines, including Immunology and Rheumatology. With its high ranking of 4th out of 73 in Rheumatology and notable standings in related fields, it serves as a crucial platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings. The journal embraces an Open Access model, enhancing the accessibility of vital research to a global audience and ensuring that knowledge dissemination is maximized. Since its inception in 2014, Arthritis & Rheumatology has been at the forefront of impactful research, fostering collaboration and innovation in tackling complex challenges within these medical disciplines. Researchers looking to explore the latest advancements and engage with cutting-edge studies in these fields will find this journal to be an essential resource.

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Advancing rheumatology through impactful research.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0889-857XFrequency: 4 issues/year

Rheumatic Disease Clinics of North America is a premier journal published by W B Saunders Co-Elsevier Inc, dedicated to advancing the field of rheumatology through comprehensive and impactful research. With an ISSN of 0889-857X and an E-ISSN of 1558-3163, this esteemed publication has been disseminating knowledge since its inception in 1987, and continues to guide clinicians and researchers alike through its insightful articles and case studies. Positioned in the 2023 Q2 quartile for Rheumatology, it ranks #31 out of 73 journals in the Scopus category of Medicine _ Rheumatology, reflecting a commendable impact factor and relevance in the academic community. Although it does not offer open access options, the journal ensures that subscribers have access to cutting-edge research and reviews that address contemporary challenges and advancements in rheumatic disease. With its authoritative content, Rheumatic Disease Clinics of North America serves as a vital resource for those striving to improve patient care and clinical outcomes in the ever-evolving landscape of rheumatology research.

Lupus Science & Medicine

Fostering collaboration for a lupus-free future.
Publisher: BMJ PUBLISHING GROUPISSN: 2053-8790Frequency: 1 issue/year

Lupus Science & Medicine is a leading open-access journal published by the BMJ Publishing Group, dedicated to advancing the understanding and treatment of lupus and related autoimmune diseases. Since its establishment in 2014, the journal has fostered an academic environment for researchers, healthcare professionals, and students, providing a platform for high-quality, evidence-based studies. With a notable impact in the fields of immunology and rheumatology, it currently holds a Q1 ranking in Rheumatology and Medicine (miscellaneous) and Q2 in Immunology, reflecting its significant contribution to these vital areas of medical research. The journal is indexed in Scopus, with a commendable rank in the 67th percentile for Rheumatology, making it a valuable resource for those seeking the latest insights into lupus management and treatment. The journal emphasizes the importance of open access, ensuring that research findings are widely available to enhance global knowledge and collaboration in the fight against lupus.

Nature Reviews Gastroenterology & Hepatology

Unveiling the Future of Digestive Health Research
Publisher: NATURE PORTFOLIOISSN: 1759-5045Frequency: 12 issues/year

Nature Reviews Gastroenterology & Hepatology is a premier academic journal published by NATURE PORTFOLIO, specializing in the vital fields of gastroenterology and hepatology. With an impressive impact factor and categorized in Q1 for both disciplines, this journal ranks at the top of its field, with Scopus rankings placing it in the 99th percentile for gastroenterology and hepatology. The journal aims to provide critical reviews that synthesize the latest research findings, clinical practices, and breakthroughs, catering to researchers, healthcare professionals, and students alike. With its wide-ranging access options, it promotes the dissemination of knowledge essential for advancements in understanding digestive and liver disorders. The journal has been committed to academic excellence since its convergence in 2009, continuing to shape the future of gastroenterological and hepatological research through rigorous peer-reviewed content.